Comment on These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains

These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains

Image source: Getty Images.This has been a rough year for biotech investors. The market cap-weighted iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) is down about 23% year to date, and some companies have been hit even harder. Shares of bluebird bio (NASDAQ: BLUE), Celldex Therapeutics, Inc. (NASDAQ: CLDX), and Ionis Pharmaceuticals, Inc.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News